GlassScriptPhysician profile
Christopher Larney Hansen
NPI 1629091228
$968.15
in general payments reported to CMS, 2019-2025
8 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.66 · 2020: $122 · 2021: $111 · 2022: $101 · 2023: $50.55 · 2024: $136 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Digirad Health, INC | $247.13 | 2025 | Cardius |
| Edwards Lifesciences Corporation | $232.97 | 2020-2021 | |
| Pfizer INC. | $181.97 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $145.74 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $73.20 | 2024 | Amvuttra |
| Amgen INC. | $45.82 | 2025 | Repatha |
| Heartflow, INC. | $23.47 | 2025 | |
| Inspire Medical Systems, INC. | $17.85 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.